In PDAC, the activation of Kras promotes the production of inflammatory cytokines, including IL-1, which activates NF-κB to promote tumor cell survival and proliferation, increased invasive and metastatic behavior, and angiogenesis [5,12,13,14]. The gene discussed is IL1A; the disease is neoplasm.